Adler R
Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Arch Ophthalmol. 1996 Jan;114(1):79-83. doi: 10.1001/archopht.1996.01100130075012.
There is still no effective treatment for retinal degenerative diseases such as retinitis pigmentosa (RP), in which the loss of photoreceptor cells causes visual loss and eventually blindness. In addition to its intrinsic scientific interest, basic research aimed at elucidating the biological mechanisms regulating the survival and function of cones and rods is also important from a clinical perspective, since it could provide a foundation for the development of therapeutic strategies for these diseases. The recent observation that photoreceptor degeneration in several RP animal models occurs through programmed cell death (apoptosis) illustrates this possibility well. This article will present a brief overview of recent research contributions toward the search for treatments for retinal degenerations of genetic origin.
对于视网膜色素变性(RP)等视网膜退行性疾病,目前仍没有有效的治疗方法,在这类疾病中,光感受器细胞的丧失会导致视力下降并最终失明。除了其内在的科学价值外,旨在阐明调节视锥细胞和视杆细胞存活及功能的生物学机制的基础研究,从临床角度来看也很重要,因为它可为这些疾病治疗策略的开发提供基础。最近在几种RP动物模型中观察到光感受器变性是通过程序性细胞死亡(凋亡)发生的,这很好地说明了这种可能性。本文将简要概述近期在寻找遗传性视网膜退行性疾病治疗方法方面的研究贡献。